Literature DB >> 29890167

Proportion of CD4+CD49b+LAG-3+ Type 1 Regulatory T Cells in the Blood of Psoriasis Patients Inversely Correlates with Psoriasis Area and Severity Index.

Jaehwan Kim1, Jongmi Lee2, Juana Gonzalez2, Judilyn Fuentes-Duculan2, Sandra Garcet2, James G Krueger3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29890167     DOI： 10.1016/j.jid.2018.05.021

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  9 in total

1.  Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsets.

Authors:  Jaehwan Kim; Jongmi Lee; Hyun Je Kim; Naoya Kameyama; Roya Nazarian; Evan Der; Steven Cohen; Emma Guttman-Yassky; Chaim Putterman; James G Krueger
Journal:  J Allergy Clin Immunol       Date:  2021-04-29       Impact factor: 10.793

2.  'Psoriasis 1' reduces T‑lymphocyte‑mediated inflammation in patients with psoriasis by inhibiting vitamin D receptor‑mediated STAT4 inactivation.

Authors:  Yang Gao; Wen Sun; Xushan Cha; Hailong Wang
Journal:  Int J Mol Med       Date:  2020-08-06       Impact factor: 4.101

3.  Looking Beyond Th17 Cells: A Role for Tr1 Cells in Ankylosing Spondylitis?

Authors:  Joanna McGinty; Nicola Brittain; Tony J Kenna
Journal:  Front Immunol       Date:  2020-12-02       Impact factor: 7.561

Review 4.  The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris.

Authors:  Jaehwan Kim; Ariana Moreno; James G Krueger
Journal:  Front Immunol       Date:  2022-08-30       Impact factor: 8.786

5.  CD4+ LAG-3+ T cells are decreased in active psoriatic arthritis patients and their restoration in vitro is mediated by TNF inhibitors.

Authors:  Smadar Gertel; Ari Polachek; Victoria Furer; David Levartovsky; Ori Elkayam
Journal:  Clin Exp Immunol       Date:  2021-08-05       Impact factor: 4.330

6.  Depletion of LAG-3+ T Cells Translated to Pharmacology and Improvement in Psoriasis Disease Activity: A Phase I Randomized Study of mAb GSK2831781.

Authors:  Joanne Ellis; Daniel J B Marks; Naren Srinivasan; Christine Barrett; Thomas G Hopkins; Anna Richards; Rainard Fuhr; Muna Albayaty; Martin Coenen; Lia Liefaard; Karen Leavens; Katherine L Nevin; Shuo Tang; Stephen A Hughes; Léa Fortunato; Ken Edwards; Yi Cui; Rabia Anselm; Christopher J Delves; Emilie Charles; Maria Feeney; Thomas M Webb; Sara J Brett; Tim S Schmidt; John Stone; Caroline O S Savage; Nicolas Wisniacki; Ruth M Tarzi
Journal:  Clin Pharmacol Ther       Date:  2020-11-24       Impact factor: 6.875

7.  Reinforcing involvement of NK cells in psoriasiform dermatitis animal model.

Authors:  Mihaela Surcel; Adriana Narcisa Munteanu; Radu-Ionuț Huică; Gheorghița Isvoranu; Ioana Ruxandra Pîrvu; Carolina Constantin; Ovidiu Bratu; Constantin Căruntu; Isadora Zaharescu; Lucica Sima; Marieta Costache; Monica Neagu
Journal:  Exp Ther Med       Date:  2019-08-30       Impact factor: 2.447

Review 8.  Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD.

Authors:  Irma Tindemans; Maria E Joosse; Janneke N Samsom
Journal:  Cells       Date:  2020-01-02       Impact factor: 6.600

Review 9.  The Yin and Yang of Type 1 Regulatory T Cells: From Discovery to Clinical Application.

Authors:  Ece Canan Sayitoglu; Robert Arthur Freeborn; Maria Grazia Roncarolo
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.